Global Circulating Tumor Cells Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2022 to 2028

Description

List of Tables

Value Market Research deeply researched the Global Circulating Tumor Cells Market to foresee a significant growth in the industry over the upcoming years. The global circulating tumor cells market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.

The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global circulating tumor cells market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this circulating tumor cells market.

The next sections of the circulating tumor cells market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.

Countries Covered in the report are as below:

North America - United States, Canada, and Mexico

Europe - United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe

Asia-Pacific - China, India, Japan, South Korea, Australia & Rest of APAC

Latin America - Brazil, Argentina, Peru, Chile & Rest of Latin America

Middle East and Africa - Saudi Arabia, UAE, Israel, South Africa

Market Segmentation in the report is as below:

By Technology

CTC Detection & Enrichment Methods

CTC Direct Detection Methods

CTC Analysis

By Application

Multiple Chromosome Abnormalities

RNA Profiling

Protein Expression

Cellular Communication

Others

By End-Use

Research & Academic Institutes

Hospital & Clinics

Diagnostic Centers

Product Code: VMR11212629

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Circulating Tumor Cells Market
2.2. Global Circulating Tumor Cells Market Snapshot

3 . CIRCULATING TUMOR CELLS - INDUSTRY ANALYSIS

3.1. Introduction
3.2. Market Drivers of Circulating Tumor Cells Market
3.3. Market Restraints of Circulating Tumor Cells Market
3.4. Opportunities of Circulating Tumor Cells Market
3.5. Trends of Circulating Tumor Cells Market
3.6. Porter's Five Force Analysis of Circulating Tumor Cells Market
3.7. Circulating Tumor Cells Market Attractiveness Analysis
- 3.7.1 Market Attractive Analysis by Technology
- 3.7.2 Market Attractive Analysis by Application
- 3.7.3 Market Attractive Analysis by End-Use
- 3.7.4 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS

4.1. Circulating Tumor Cells Value Chain Analysis
4.2. Circulating Tumor Cells Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Circulating Tumor Cells Raw Material Manufactures List
- 4.2.3. Price Trend of Circulating Tumor Cells Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

5.1. Impact Analysis of Covid-19 Outbreak on Circulating Tumor Cells Market
- 5.1.1. Direct Impact on Production
- 5.1.2. Supply Chain and Market Disruption
- 5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Circulating Tumor Cells Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Circulating Tumor Cells Market Size in 2020, by Scenario
5.5. COVID-19: Micro and Macro Factor Analysis on Circulating Tumor Cells Market

6 . GLOBAL CIRCULATING TUMOR CELLS MARKET ANALYSIS BY TECHNOLOGY

6.1 Overview by Technology
6.2 Global Circulating Tumor Cells Market Analysis by Technology
6.3 Market Analysis of CTC Detection & Enrichment Methods by Regions
6.4 Market Analysis of CTC Direct Detection Methods by Regions
6.6 Market Analysis of CTC Analysis by Regions

7 . GLOBAL CIRCULATING TUMOR CELLS MARKET ANALYSIS BY APPLICATION

7.1 Overview by Application
7.2 Global Circulating Tumor Cells Market Analysis by Application
7.3 Market Analysis of Multiple Chromosome Abnormalities by Regions
7.4 Market Analysis of RNA Profiling by Regions
7.5 Market Analysis of Protein Expression by Regions
7.6 Market Analysis of Cellular Communication by Regions
7.7 Market Analysis of Others by Regions

8 . GLOBAL CIRCULATING TUMOR CELLS MARKET ANALYSIS BY END-USE

8.1 Overview by End-Use
8.2 Global Circulating Tumor Cells Market Analysis by End-Use
8.3 Market Analysis of Research & Academic Institutes by Regions
8.4 Market Analysis of Hospital & Clinics by Regions
8.5 Market Analysis of Diagnostic Centers by Regions

9 . GLOBAL CIRCULATING TUMOR CELLS MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America
- 9.3.1. Overview
- 9.3.2. North America Circulating Tumor Cells Market Estimate by Country
- 9.3.3. United State
- 9.3.4. Rest of North America
9.4. Europe
- 9.4.1. Overview
- 9.4.2. Europe Circulating Tumor Cells Market Estimate by Market Segment
- 9.4.3. Europe Circulating Tumor Cells Market Estimate by Country
- 9.4.4. United Kingdom
- 9.4.5. France
- 9.4.6. Germany
- 9.4.7 Rest of Europe
9.5. Asia Pacific
- 9.5.1. Overview
- 9.5.2. Asia Pacific Circulating Tumor Cells Market Estimate by Market Segment
- 9.5.3. Asia Pacific Circulating Tumor Cells Market Estimate by Country
- 9.5.4. China
- 9.5.5. Japan
- 9.5.6. India
- 9.5.7. Rest of Asia Pacific
9.6. Latin America
- 9.6.1. Overview
- 9.6.2. Latin America Circulating Tumor Cells Market Estimate by Market Segment
- 9.6.3. Latin America Circulating Tumor Cells Market Estimate by Country
- 9.6.4. Brazil
- 9.6.5. Rest of Latin America
9.7. Middle East & Africa
- 9.7.1. Overview
- 9.7.2. Middle East & Africa Circulating Tumor Cells Market Estimate by Market Segment
- 9.7.3. Middle East & Africa Circulating Tumor Cells Market Estimate by Country
- 9.7.4. Middle East
- 9.7.5. Africa

10 . COMPETITIVE LANDSCAPE OF THE CIRCULATING TUMOR CELLS COMPANIES

10.1. Circulating Tumor Cells Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF CIRCULATING TUMOR CELLS INDUSTRY

11.1. Company Share Analysis
11.2. Market Concentration Rate
11.3. Aviva Biosciences
- 11.3.1. Company Overview
- 11.3.2. Financials
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Advanced Cell Diagnostics Inc.
- 11.4.1. Company Overview
- 11.4.2. Financials
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. Biocept Inc.
- 11.5.1. Company Overview
- 11.5.2. Financials
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. LungLife AI Inc.
- 11.6.1. Company Overview
- 11.6.2. Financials
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. Creatv Micro Tech, Inc.
- 11.7.1. Company Overview
- 11.7.2. Financials
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. Miltenyi Biotec
- 11.8.1. Company Overview
- 11.8.2. Financials
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. Menarini Silicon Biosystems
- 11.9.1. Company Overview
- 11.9.2. Financials
- 11.9.3. Products
- 11.9.4. Recent Developments
11.10. Precision for Medicine
- 11.10.1. Company Overview
- 11.10.2. Financials
- 11.10.3. Products
- 11.10.4. Recent Developments
11.11. Qiagen NV
- 11.11.1. Company Overview
- 11.11.2. Financials
- 11.11.3. Products
- 11.11.4. Recent Developments

Note - In company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies